{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:01:22Z","timestamp":1787961682645,"version":"build-2784847793"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":419,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cardiac resynchronization therapy (CRT) is guideline recommended for the treatment of symptomatic heart failure (HF) with reduced left ventricular ejection fraction and prolonged QRS. However, patients with common comorbidities, such as persistent\/permanent atrial fibrillation (AF), are often under-represented in clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Strategic Management to Optimize Response to Cardiac Resynchronization Therapy (SMART) registry (NCT03075215) was a global, multicentre, registry that enrolled de novo CRT implants, or upgrade from pacemaker or implantable cardioverter defibrillator to CRT-defibrillator (CRT-D), using a quadripolar left ventricular lead in real-world clinical practice. The primary endpoint was CRT response between baseline and 12 month follow-up defined as a clinical composite score (CCS) consisting of all-cause mortality, HF-associated hospitalization, New York Heart Association (NYHA) class and quality of life global assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The registry enrolled 2035 patients, of which 1558 had completed CCS outcomes at 12 months. The patient cohort was 33.0% female, mean age at enrolment was 67.5 \u00b1 10.4 years and the mean left ventricular ejection fraction was 29.6 \u00b1 7.9%. Notably, there was a high prevalence of mildly symptomatic patients (NYHA class I\/II 51.3%), non-left bundle branch block (LBBB) morphology (38.0%), AF (37.2%) and diabetes mellitus (34.7%) at baseline. CCS at 12 months improved in 58.9% (n = 917) of patients; 20.1% (n = 313) of patients stabilized and 21.0% (n = 328) worsened. Several patient characteristics were associated with a lower likelihood of response to CRT including older age, ischaemic aetiology, renal dysfunction, AF, non-LBBB morphology and diabetes. Higher HF hospitalization (P &amp;lt; 0.001) and all-cause mortality (P &amp;lt; 0.001) were observed in patients with AF. These patients also had lower percentages of ventricular pacing than patients in sinus rhythm at baseline and follow-up (P &amp;lt; 0.001, both). A further association between AF and non-LBBB was observed with 81.4% of AF non-LBBB patients experiencing an HF hospitalization compared with 92.5% of non-AF LBBB patients (P &amp;lt; 0.001). Mortality between subgroups was also statistically significant (P = 0.019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This large, global registry enrolled a CRT-D population with higher incidence of comorbidities that have been historically underrepresented in clinical trials and provides new insight into factors influencing response to CRT. As defined by CCS, 58.9% of patients improved and 20.1% stabilized. Patients with AF had particularly worse clinical outcomes, higher HF hospitalization and mortality rates and lower percentages of ventricular pacing. High incidence of HF hospitalization in patients with AF and non-LBBB in this real-world cohort suggests that ablation may play an important role in increasing future CRT response rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15190","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T03:25:19Z","timestamp":1735183519000},"page":"1832-1847","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-World Outcomes in Cardiac Resynchronization Therapy Patients: Primary Results of the SMART Registry"],"prefix":"10.1093","volume":"12","author":[{"given":"Ignacio","family":"Garc\u00eda-Bolao","sequence":"first","affiliation":[{"name":"Department of Cardiology and Cardiac Surgery, Arrhythmia Unit, Navarra Institute for Health Research, Clinica Universidad de Navarra , Pamplona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy S.","family":"Gardner","sequence":"additional","affiliation":[{"name":"Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital , Clydebank ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gras","sequence":"additional","affiliation":[{"name":"L'Hopital Prive du Confluent , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D'Onofrio","sequence":"additional","affiliation":[{"name":"AORN Ospedali dei Colli\u2014Monaldi Hospital , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mark","sequence":"additional","affiliation":[{"name":"Cardiology Associates of the Delaware Valley , Haddon Heights, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"Nair","sequence":"additional","affiliation":[{"name":"Arrythmia Research Group , Jonesboro, Arkansas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lellouche","sequence":"additional","affiliation":[{"name":"APHP , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Novak","sequence":"additional","affiliation":[{"name":"Faculty Hospital U sv Anny , Brno ,","place":["Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Lo","sequence":"additional","affiliation":[{"name":"VA Loma Linda, Loma Linda , Loma Linda, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engwooi","family":"Chew","sequence":"additional","affiliation":[{"name":"Belfast City Hospital Trust , Belfast ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wright","sequence":"additional","affiliation":[{"name":"Liverpool Heart and Chest Hospital , Liverpool ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Cardiovascular Associates of Mesa , Mesa, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bertini","sequence":"additional","affiliation":[{"name":"Cardiovascular Unit, Azienda Ospedaliero\u2014Universitaria di Ferrara , Ferrara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Veraghtert","sequence":"additional","affiliation":[{"name":"Boston Scientific Corporation , St. Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Harbin","sequence":"additional","affiliation":[{"name":"Boston Scientific Corporation , St. Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Matznick","sequence":"additional","affiliation":[{"name":"Boston Scientific Corporation , St. Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yong","sequence":"additional","affiliation":[{"name":"Boston Scientific Corporation , St. Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Boston Scientific Corporation , St. Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"2026021804251186600_ehf215190-bib-0001","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"key":"2026021804251186600_ehf215190-bib-0002","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"2026021804251186600_ehf215190-bib-0003","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"2026021804251186600_ehf215190-bib-0004","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026021804251186600_ehf215190-bib-0005","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"2026021804251186600_ehf215190-bib-0006","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.hrthm.2012.07.025","article-title":"2012 EHRA\/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management","volume":"9","author":"European Heart Rhythm A","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026021804251186600_ehf215190-bib-0007","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804251186600_ehf215190-bib-0008","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1054\/jcaf.2001.25652","article-title":"Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure","volume":"7","author":"Packer","year":"2001","journal-title":"J Card Fail"},{"key":"2026021804251186600_ehf215190-bib-0009","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.hrthm.2006.07.034","article-title":"Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy","volume":"3","author":"Singh","year":"2006","journal-title":"Heart Rhythm"},{"key":"2026021804251186600_ehf215190-bib-0010","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1093\/eurheartj\/ehr329","article-title":"The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy","volume":"32","author":"Gold","year":"2011","journal-title":"Eur Heart J"},{"key":"2026021804251186600_ehf215190-bib-0011","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/jce.12381","article-title":"Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration","volume":"25","author":"D'Onofrio","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026021804251186600_ehf215190-bib-0012","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1016\/j.ijcard.2013.07.201","article-title":"The interventricular conduction time is associated with response to cardiac resynchronization therapy: interventricular electrical delay","volume":"168","author":"D'Onofrio","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026021804251186600_ehf215190-bib-0013","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.hrthm.2017.10.016","article-title":"The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy","volume":"14","author":"Gold","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026021804251186600_ehf215190-bib-0014","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/eurheartj\/ehw526","article-title":"Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial","volume":"38","author":"Brugada","year":"2017","journal-title":"Eur Heart J"},{"key":"2026021804251186600_ehf215190-bib-0015","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/CIRCULATIONAHA.110.992552","article-title":"Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy","volume":"122","author":"Ellenbogen","year":"2010","journal-title":"Circulation"},{"key":"2026021804251186600_ehf215190-bib-0016","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.hrthm.2013.07.007","article-title":"Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial","volume":"10","author":"Birnie","year":"2013","journal-title":"Heart Rhythm"},{"key":"2026021804251186600_ehf215190-bib-0017","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jacep.2016.02.018","article-title":"Interventricular electrical delay is predictive of response to cardiac resynchronization therapy","volume":"2","author":"Gold","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"2026021804251186600_ehf215190-bib-0018","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.hrthm.2013.03.009","article-title":"The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy","volume":"10","author":"Gold","year":"2013","journal-title":"Heart Rhythm"},{"key":"2026021804251186600_ehf215190-bib-0019","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jacep.2020.04.034","article-title":"Targeted left ventricular Lead implantation strategy for non-left bundle branch block patients: the ENHANCE CRT study","volume":"6","author":"Singh","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2026021804251186600_ehf215190-bib-0020","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"2026021804251186600_ehf215190-bib-0021","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1401426","article-title":"Survival with cardiac-resynchronization therapy in mild heart failure","volume":"370","author":"Goldenberg","year":"2014","journal-title":"N Engl J Med"},{"key":"2026021804251186600_ehf215190-bib-0022","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"2026021804251186600_ehf215190-bib-0023","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/ehf2.13192","article-title":"Real-world outcomes in cardiac resynchronization therapy patients: design and baseline demographics of the SMART-registry","volume":"8","author":"Gardner","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026021804251186600_ehf215190-bib-0024","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.006055","article-title":"Effect of interventricular electrical delay on atrioventricular optimization for cardiac resynchronization therapy","volume":"11","author":"Gold","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026021804251186600_ehf215190-bib-0025","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ahj.2012.02.007","article-title":"A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial","volume":"163","author":"Krum","year":"2012","journal-title":"Am Heart J"},{"key":"2026021804251186600_ehf215190-bib-0026","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.amjcard.2021.10.027","article-title":"Usefulness of multisite ventricular pacing in nonresponders to cardiac resynchronization therapy","volume":"164","author":"Saba","year":"2022","journal-title":"Am J Cardiol"},{"key":"2026021804251186600_ehf215190-bib-0027","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.jacc.2017.03.531","article-title":"Multiple comorbidities and response to cardiac resynchronization therapy: MADIT-CRT long-term follow-up","volume":"69","author":"Zeitler","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026021804251186600_ehf215190-bib-0028","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/eurheartj\/ehaa1057","article-title":"Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score","volume":"42","author":"Younis","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804251186600_ehf215190-bib-0029","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.hrthm.2012.07.009","article-title":"Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial","volume":"9","author":"Martin","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026021804251186600_ehf215190-bib-0030","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/pace.13389","article-title":"Long-term electrical performance of Attain Performa quadripolar left ventricular leads with all steroid-eluting electrodes: results from a large worldwide clinical trial","volume":"41","author":"Lin","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026021804251186600_ehf215190-bib-0031","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/europace\/euw094","article-title":"Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP)","volume":"19","author":"Forleo","year":"2017","journal-title":"Europace"},{"key":"2026021804251186600_ehf215190-bib-0032","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.hroo.2021.09.003","article-title":"Atrial fibrillation in cardiac resynchronization therapy","volume":"O2","author":"Elliott","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026021804251186600_ehf215190-bib-0033","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"2026021804251186600_ehf215190-bib-0034","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10840-015-0058-5","article-title":"Atrioventricular and ventricular-to-ventricular programming in patients with cardiac resynchronization therapy: results from ALTITUDE","volume":"44","author":"Steinberg","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"key":"2026021804251186600_ehf215190-bib-0035","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCHEARTFAILURE.112.968867","article-title":"Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT)","volume":"5","author":"Healey","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026021804251186600_ehf215190-bib-0036","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021804251186600_ehf215190-bib-0037","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000937","article-title":"Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"6","author":"Mustafa","year":"2019","journal-title":"Open Heart"},{"key":"2026021804251186600_ehf215190-bib-0038","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/clc.22312","article-title":"Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis","volume":"37","author":"Yin","year":"2014","journal-title":"Clin Cardiol"},{"key":"2026021804251186600_ehf215190-bib-0039","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","article-title":"AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial","volume":"42","author":"Brignole","year":"2021","journal-title":"Eur Heart J"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1832\/66956049\/eschf_12_3_1832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1832\/66956049\/eschf_12_3_1832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:25:20Z","timestamp":1771406720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/3\/1832\/8488331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,12,26]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15190","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"2024-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}